These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

359 related articles for article (PubMed ID: 35055123)

  • 1. Cellular and Molecular Alterations Underlying Abnormal Bone Growth in X-Linked Hypophosphatemia.
    Fuente R; García-Bengoa M; Fernández-Iglesias Á; Gil-Peña H; Santos F; López JM
    Int J Mol Sci; 2022 Jan; 23(2):. PubMed ID: 35055123
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Distinct roles for intrinsic osteocyte abnormalities and systemic factors in regulation of FGF23 and bone mineralization in Hyp mice.
    Liu S; Tang W; Zhou J; Vierthaler L; Quarles LD
    Am J Physiol Endocrinol Metab; 2007 Dec; 293(6):E1636-44. PubMed ID: 17848631
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safety and efficacy of burosumab in improving phosphate metabolism, bone health, and quality of life in adolescents with X-linked hypophosphatemic rickets.
    Baroncelli GI; Grandone A; Aversa A; Sessa MR; Pelosini C; Michelucci A; Toschi B; Manca M; Isola A; Comberiati P
    Eur J Med Genet; 2024 Aug; 70():104958. PubMed ID: 38950880
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Phex mutation in a murine model of X-linked hypophosphatemia alters phosphate responsiveness of bone cells.
    Ichikawa S; Austin AM; Gray AK; Econs MJ
    J Bone Miner Res; 2012 Feb; 27(2):453-60. PubMed ID: 22006791
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mineralized tissues in hypophosphatemic rickets.
    Robinson ME; AlQuorain H; Murshed M; Rauch F
    Pediatr Nephrol; 2020 Oct; 35(10):1843-1854. PubMed ID: 31392510
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Consensus Recommendations for the Diagnosis and Management of X-Linked Hypophosphatemia in Belgium.
    Laurent MR; De Schepper J; Trouet D; Godefroid N; Boros E; Heinrichs C; Bravenboer B; Velkeniers B; Lammens J; Harvengt P; Cavalier E; Kaux JF; Lombet J; De Waele K; Verroken C; van Hoeck K; Mortier GR; Levtchenko E; Vande Walle J
    Front Endocrinol (Lausanne); 2021; 12():641543. PubMed ID: 33815294
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genotype-phenotype analysis, and assessment of the importance of the zinc-binding site in PHEX in Japanese patients with X-linked hypophosphatemic rickets using 3D structure modeling.
    Ishihara Y; Ohata Y; Takeyari S; Kitaoka T; Fujiwara M; Nakano Y; Yamamoto K; Yamada C; Yamamoto K; Michigami T; Mabe H; Yamaguchi T; Matsui K; Tamada I; Namba N; Yamamoto A; Etoh J; Kawaguchi A; Kosugi R; Ozono K; Kubota T
    Bone; 2021 Dec; 153():116135. PubMed ID: 34333162
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alterations of bone material properties in adult patients with X-linked hypophosphatemia (XLH).
    Fratzl-Zelman N; Gamsjaeger S; Blouin S; Kocijan R; Plasenzotti P; Rokidi S; Nawrot-Wawrzyniak K; Roetzer K; Uyanik G; Haeusler G; Shane E; Cohen A; Klaushofer K; Paschalis EP; Roschger P; Fratzl P; Zwerina J; Zwettler E
    J Struct Biol; 2020 Sep; 211(3):107556. PubMed ID: 32619592
    [TBL] [Abstract][Full Text] [Related]  

  • 9. X-Linked Hypophosphatemia: Uniquely Mild Disease Associated With PHEX 3'-UTR Mutation c.*231A>G (A Retrospective Case-Control Study).
    Smith PS; Gottesman GS; Zhang F; Cook F; Ramirez B; Wenkert D; Wollberg V; Huskey M; Mumm S; Whyte MP
    J Bone Miner Res; 2020 May; 35(5):920-931. PubMed ID: 31910300
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic analysis of three families with X-linked dominant hypophosphatemic rickets.
    Lin X; Zhu Y; Luo J; Huang J
    J Pediatr Endocrinol Metab; 2018 Jul; 31(7):789-797. PubMed ID: 29858904
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Spectrum of PHEX Mutations and FGF23 Profiles in a Taiwanese Cohort With X-Linked Hypophosphatemia Including 102 Patients.
    Su PH; Yu JS; Wu YZ; Tsai YS; Lo FS; Lin JL; Chao MC; Hsu CC; Ke YY; Chiu PC; Chen JC; Huang YH; Lin SP; Chou YY; Ting WH; Wang SY; Chiu CF; Huang YC; Hsiao HP; Lin CH; Wang CH; Bau DT; Lin CY
    In Vivo; 2024; 38(1):341-350. PubMed ID: 38148081
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of 2 novel mutations of PHEX gene inducing X-linked dominant hypophosphatemia rickets in 2 families: Two case reports.
    Gao Y; Wang ZM; Li XL
    Medicine (Baltimore); 2018 Aug; 97(31):e11453. PubMed ID: 30075510
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sclerostin antibody improves phosphate metabolism hormones, bone formation rates, and bone mass in adult Hyp mice.
    Carpenter KA; Davison R; Shakthivel S; Anderson KD; Ko FC; Ross RD
    Bone; 2022 Jan; 154():116201. PubMed ID: 34537437
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phenotypic characterization of X-linked hypophosphatemia in pediatric Spanish population.
    Rodríguez-Rubio E; Gil-Peña H; Chocron S; Madariaga L; de la Cerda-Ojeda F; Fernández-Fernández M; de Lucas-Collantes C; Gil M; Luis-Yanes MI; Vergara I; González-Rodríguez JD; Ferrando S; Antón-Gamero M; Carrasco Hidalgo-Barquero M; Fernández-Escribano A; Fernández-Maseda MÁ; Espinosa L; Oliet A; Vicente A; Ariceta G; Santos F;
    Orphanet J Rare Dis; 2021 Feb; 16(1):104. PubMed ID: 33639975
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Complex intrinsic abnormalities in osteoblast lineage cells of X-linked hypophosphatemia: Analysis of human iPS cell models generated by CRISPR/Cas9-mediated gene ablation.
    Nakanishi T; Yamazaki M; Tachikawa K; Ueta A; Kawai M; Ozono K; Michigami T
    Bone; 2024 Apr; 181():117044. PubMed ID: 38331306
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dosage effect of a Phex mutation in a murine model of X-linked hypophosphatemia.
    Ichikawa S; Gray AK; Bikorimana E; Econs MJ
    Calcif Tissue Int; 2013 Aug; 93(2):155-62. PubMed ID: 23700148
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CRISPR/Cas9-mediated mutation of PHEX in rabbit recapitulates human X-linked hypophosphatemia (XLH).
    Sui T; Yuan L; Liu H; Chen M; Deng J; Wang Y; Li Z; Lai L
    Hum Mol Genet; 2016 Jul; 25(13):2661-2671. PubMed ID: 27126636
    [TBL] [Abstract][Full Text] [Related]  

  • 18. FGF23 and its role in X-linked hypophosphatemia-related morbidity.
    Beck-Nielsen SS; Mughal Z; Haffner D; Nilsson O; Levtchenko E; Ariceta G; de Lucas Collantes C; Schnabel D; Jandhyala R; Mäkitie O
    Orphanet J Rare Dis; 2019 Feb; 14(1):58. PubMed ID: 30808384
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular Diagnoses of X-Linked and Other Genetic Hypophosphatemias: Results From a Sponsored Genetic Testing Program.
    Rush ET; Johnson B; Aradhya S; Beltran D; Bristow SL; Eisenbeis S; Guerra NE; Krolczyk S; Miller N; Morales A; Ramesan P; Sarafrazi S; Truty R; Dahir K
    J Bone Miner Res; 2022 Feb; 37(2):202-214. PubMed ID: 34633109
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel PHEX gene locus-specific database: Comprehensive characterization of vast number of variants associated with X-linked hypophosphatemia (XLH).
    Sarafrazi S; Daugherty SC; Miller N; Boada P; Carpenter TO; Chunn L; Dill K; Econs MJ; Eisenbeis S; Imel EA; Johnson B; Kiel MJ; Krolczyk S; Ramesan P; Truty R; Sabbagh Y
    Hum Mutat; 2022 Feb; 43(2):143-157. PubMed ID: 34806794
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.